Midwives for MOMS Act of 2025

The Midwives for MOMS Act of 2025, HR6394, establishes a grant program under Title VII of the Public Health Service Act, specifically section 760A. This program authorizes $15 million in appropriations for fiscal years 2026 through 2030. The funds are distributed as follows: 50% for direct student support in accredited midwifery programs, 25% for establishing or expanding accredited midwifery programs, and 25% for securing or supporting qualified preceptors. The bill prioritizes institutions that focus on students planning to practice in health professional shortage areas and those recruiting from rural and economically disadvantaged communities. This bill is in the early stages, having been referred to the House Committee on Energy and Commerce. The money trail for this bill flows directly to institutions of higher education. These grants are not for direct procurement of goods or services from publicly traded companies. Instead, they fund educational programs and student support. While the bill aims to address maternity care shortages, the $15 million over five years is a relatively small amount in the context of the broader healthcare market. No specific publicly traded companies are positioned to directly receive these grants or experience a material increase in demand for their products or services as a direct result of this funding. Historically, similar targeted educational funding bills have not produced significant, immediate market movements for specific companies. For example, the Nurse Reinvestment Act of 2002 (P.L. 107-205) aimed to address nursing shortages through scholarships and grants. While it supported the nursing profession, it did not cause measurable stock price movements for healthcare providers or educational service companies. The impact of such legislation is typically long-term and diffuse, affecting labor supply rather than corporate revenue streams directly. The bill's sponsor, Rep. Hinson, is a junior member, indicating lower legislative momentum compared to a bill sponsored by committee leadership. There are no specific publicly traded winners or losers identified from this bill. The funding goes to educational institutions, which are typically non-profit or state-funded entities. Healthcare providers, such as $HCA (HCA Healthcare) or $UHS (Universal Health Services), may see a long-term, indirect benefit from an increased supply of midwives, but this impact is not quantifiable or immediate given the scale of funding. Companies providing educational technology or services might see a marginal, unquantifiable increase in demand from educational institutions, but this is not a direct or material impact. The next step for HR6394 is consideration by the House Committee on Energy and Commerce. If it passes committee, it would then proceed to a floor vote in the House. Given the early stage and the relatively small funding amount, the timeline for enactment is uncertain, and market impact remains negligible in the near term. The funding would not become available until fiscal year 2026 at the earliest.